Aug 12 (Reuters) - Novartis (NOVN.S), opens new tab failed to convince a federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster ...

Novartis’ latest effort to block a generic challenger to blockbuster heart med Entresto has come up short, this time in a federal appeals court. The company has been defending against what could ...

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from approving it ...

Rise and shine, everyone, another busy day is on the way. Our mascots, for instance, got off to a particularly busy start, having spotted a feline creature nearby that sent them into a tizzy. Such is ...

The judge temporarily suspended MSN Pharmaceuticals' sales while Novartis appealed to the U.S. Court of Appeals for the Federal Circuit. Despite the legal challenges, Novartis maintains its financial ...